NEWS

What we are up to:

PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance to Market CAMPYLOBACTER QUIK CHEK and CAMPYLOBACTER CHEK Tests

  BLACKSBURG, Va. – January 23, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the CAMPYLOBACTER QUIK CHEK™ and the CAMPYLOBACTER CHEK™ tests. Both are intended to aid diagnosis of campylobacteriosis, one of the most common … Continue reading

January 23, 2018

PRESS RELEASE: Phoenix Lab to Offer GIARDIA VET CHEK From TECHLAB®

BLACKSBURG, Va. and MUKILTEO, Wash. – January 11, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEK™. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the … Continue reading

January 11, 2018

PRESS RELEASE: Advanced Veterinary Laboratory to Offer GIARDIA VET CHEK From TECHLAB®

BLACKSBURG, Va. – January 3, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it will supply Advanced Veterinary Laboratory (AVL) with the GIARDIA VET CHEK™ test, the first USDA licensed Giardia microwell ELISA available for use in dogs and cats. The GIARDIA VET CHEK™ test offers … Continue reading

January 3, 2018

PRESS RELEASE: TECHLAB® Receives USDA Establishment License and Product License for GIARDIA VET CHEK™

BLACKSBURG, Va. – November 8, 2017 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEK™. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the first … Continue reading

November 17, 2017

PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance To Market TRI-COMBO PARASITE SCREEN™ To Aid Clinicians In The Diagnosis Of Giardiasis, Cryptosporidiosis, And Amebiasis

Read the full release here. BLACKSBURG, Va., July 13, 2017 /PRNewswire/ — TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the TRI-COMBO PARASITE SCREEN™ test. The TRI-COMBO PARASITE SCREEN ™ test provides a complete analysis for Giardia, Cryptosporidium, and Entamoeba histolytica, the three most common intestinal protozoan … Continue reading

July 13, 2017

PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance To Market E. HISTOLYTICA QUIK CHEK™ To Aid Clinicians In The Diagnosis Of Amebiasis Caused By The E. Histolytica Parasite

Read the full release here. BLACKSBURG, Va., June 13, 2017 /PRNewswire/ — TECHLAB®,® Inc., a leading developer and manufacturer of rapid, non-invasive diagnostic tests for gastrointestinal disease, today announced that it received U.S. Food and Drug Administration (FDA) clearance for E. HISTOLYTICA QUIK CHEK™ test.  E. HISTOLYTICA QUIK CHEK™ test is the only rapid diagnostic test that specifically detects pathogenic E. histolytica and does not … Continue reading

June 13, 2017

PRESS RELEASE: TECHLAB® To Showcase Its C. DIFF QUIK CHEK COMPLETE® At 2017 American Society For Microbiology Microbe Meeting

Read the full release here. BLACKSBURG, Va., May 30, 2017 /PRNewswire/ — TECHLAB® Inc., a leading developer and manufacturer of rapid, non-invasive diagnostic tests for gastrointestinal disease, today announced that it will be showcasing C. DIFF QUIK CHEK COMPLETE® at the American Society for Microbiology Microbe 2017 meeting in New Orleans, June 1-5. C. DIFF QUIK CHEK COMPLETE® is the only test that simultaneously detects and differentiates … Continue reading

May 30, 2017

PRESS RELEASE: Pharos Capital Acquires TECHLAB, Leading Developer of Gastrointestinal Disease Diagnostics

Read the full release here. DALLAS & NASHVILLE, Tenn.–(BUSINESS WIRE)–Pharos Capital Group, LLC (“Pharos”), a private equity firm based in Dallas and Nashville, announced it has acquired a controlling position in TechLab, Inc. (“TechLab” or “the Company”), a developer and manufacturer of rapid, non-invasive diagnostic tests for gastrointestinal disease. Pharos is acquiring its stake from … Continue reading

September 19, 2016

TECHLAB® to sponsor Life Science Forum

TECHLAB® is sponsoring the 8th annual Southwest Virginia Life Science Forum on April 7 at the Virginia Tech Integrated Life Sciences Building. This Roanoke-Blacksburg Technology Council event brings together innovators from the region to share ideas and increase collaboration… Continue reading

May 11, 2016

Coming Up: 2015 Tradeshows

We would love to talk with you at one of our tradeshow booths. Visit us in Copenhagen, Denmark at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) April 25-28 Booth #211 & 212, Washington, DC at Digestive Disease Week (DDW) May 17-19 Booth #3437, or at the American Society for Microbiology (ASM) General Meeting … Continue reading

March 25, 2015